12
|
Sanchez-Alonso JL, Bhargava A, O'Hara T, Glukhov AV, Schobesberger S, Bhogal N, Sikkel MB, Mansfield C, Korchev YE, Lyon AR, Punjabi PP, Nikolaev VO, Trayanova NA, Gorelik J. Microdomain-Specific Modulation of L-Type Calcium Channels Leads to Triggered Ventricular Arrhythmia in Heart Failure. Circ Res 2016; 119:944-55. [PMID: 27572487 PMCID: PMC5045818 DOI: 10.1161/circresaha.116.308698] [Citation(s) in RCA: 80] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/10/2016] [Accepted: 08/24/2016] [Indexed: 11/22/2022]
Abstract
Supplemental Digital Content is available in the text. Rationale: Disruption in subcellular targeting of Ca2+ signaling complexes secondary to changes in cardiac myocyte structure may contribute to the pathophysiology of a variety of cardiac diseases, including heart failure (HF) and certain arrhythmias. Objective: To explore microdomain-targeted remodeling of ventricular L-type Ca2+ channels (LTCCs) in HF. Methods and Results: Super-resolution scanning patch-clamp, confocal and fluorescence microscopy were used to explore the distribution of single LTCCs in different membrane microdomains of nonfailing and failing human and rat ventricular myocytes. Disruption of membrane structure in both species led to the redistribution of functional LTCCs from their canonical location in transversal tubules (T-tubules) to the non-native crest of the sarcolemma, where their open probability was dramatically increased (0.034±0.011 versus 0.154±0.027, P<0.001). High open probability was linked to enhance calcium–calmodulin kinase II–mediated phosphorylation in non-native microdomains and resulted in an elevated ICa,L window current, which contributed to the development of early afterdepolarizations. A novel model of LTCC function in HF was developed; after its validation with experimental data, the model was used to ascertain how HF-induced T-tubule loss led to altered LTCC function and early afterdepolarizations. The HF myocyte model was then implemented in a 3-dimensional left ventricle model, demonstrating that such early afterdepolarizations can propagate and initiate reentrant arrhythmias. Conclusions: Microdomain-targeted remodeling of LTCC properties is an important event in pathways that may contribute to ventricular arrhythmogenesis in the settings of HF-associated remodeling. This extends beyond the classical concept of electric remodeling in HF and adds a new dimension to cardiovascular disease.
Collapse
Affiliation(s)
- Jose L Sanchez-Alonso
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Anamika Bhargava
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Thomas O'Hara
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Alexey V Glukhov
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Sophie Schobesberger
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Navneet Bhogal
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Markus B Sikkel
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Catherine Mansfield
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Yuri E Korchev
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Alexander R Lyon
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Prakash P Punjabi
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Viacheslav O Nikolaev
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Natalia A Trayanova
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.)
| | - Julia Gorelik
- From the Department of Cardiovascular Sciences, Imperial Centre for Translational and Experimental Medicine, National Heart and Lung Institute (J.L.S.-A., A.B., A.V.G., S.S., N.B., M.B.S., C.M., A.R.L., P.P.P., J.G.), Department of Medicine (Y.E.K.), and Department of Cardiothoracic Surgery, Hammersmith Hospital, National Heart and Lung Institute (P.P.P.), Imperial College London, United Kingdom; Department of Biomedical Engineering and Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD (T.O., N.A.T.); NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom (A.R.L.); Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (S.S., V.O.N.); and Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India (A.B.).
| |
Collapse
|